Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

Sanofi reception

Sanofi pulls development of blood cancer drug

Fedratinib linked to brain disorder during clinical trials

- PMLiVE

Baxter licenses cancer drug from CTI in $172m deal

Pacritinib is being investigated to treat blood disorder myelofibrosis

Bayer symbol

EU approval for Bayer’s prostate cancer drug

Xofigo wins marketing authorisation from European Commission

- PMLiVE

MedImmune appoints head of research

Yong-Jun Liu to lead R&D at AstraZeneca biologics subsidiary

- PMLiVE

New shores: The shift from selling pills

The shift from just selling pills to developing value-added services has only just begun

- PMLiVE

He who dares wins

The benefits of including medical experts in your brand planning team

Lucid Group Communications Limited

- PMLiVE

How Pfizer reclaimed its Twitter brand

Company explains how it took back its name on the social network

- PMLiVE

Lilly invests $700m in insulin manufacturing

Expands plants in Puerto Rico, France, China and US

- PMLiVE

Life sciences outsourcing trend continues with customer databases

Increasing number of executives plan to partner with third parties

- PMLiVE

One in ten people could have diabetes by 2035

Disease surge expected to hit every country in the world

- PMLiVE

FDA panel backs sleep pattern drug for blind

Vanda’s Hetlioz intended to improve circadian rhythms in people who cannot see

- PMLiVE

Sales down at Merck Serono on Rebif pressure

New MS drugs impact pharma company’s revenues

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links